[Therapeutic results in peripheral and cerebrovascular blood circulation disorders following the administration of Dusodril].
D000368:Aged; D000779:Anesthetics, Local / Q000494:pharmacology / Q000627:therapeutic use*; D002560:Cerebrovascular Circulation / Q000187:drug effects*; D002561:Cerebrovascular Disorders / Q000188:drug therapy*; D003327:Coronary Disease / Q000188:drug therapy; D005021:Ethylamines / Q000494:pharmacology / Q000627:therapeutic use; D005663:Furans / Q000494:pharmacology / Q000627:therapeutic use*; D006801:Humans; D007383:Intermittent Claudication / Q000188:drug therapy; D008875:Middle Aged; D009281:Naphthalenes / Q000494:pharmacology / Q000627:therapeutic use; D010276:Parasympatholytics / Q000494:pharmacology / Q000627:therapeutic use; D011422:Propionates / Q000494:pharmacology / Q000627:therapeutic use; D013565:Sympatholytics / Q000494:pharmacology / Q000627:therapeutic use*
D000779:Anesthetics, Local; D005021:Ethylamines; D005663:Furans; D009281:Naphthalenes; D010276:Parasympatholytics; D011422:Propionates; D013565:Sympatholytics
Behandlungsergebnisse bei peripheren und zerebral-vaskulären Durchblutungsstörungen nach Anwendung von Dusodril.